Low Dose Naltrexone (LDN) is an off-label use of the drug naltrexone, prescribed at significantly lower doses than typically used for opioid addiction. It is theorized to modulate the immune system and reduce inflammation. Individuals considering or beginning LDN therapy often seek information regarding the anticipated timeframe for observing noticeable effects, specifically in relation to inflammation-related symptoms.
The perceived benefit of LDN lies in its potential to manage inflammatory conditions with fewer side effects than conventional treatments. Historical context reveals that while naltrexone has been available for decades, the application of very low doses for immunological purposes represents a more recent development. This approach has gained traction among individuals seeking alternative or adjunctive therapies for autoimmune disorders and chronic inflammatory diseases, which often involve debilitating and persistent discomfort.